Medulloblastoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG ACNS0332 Protocol A Variant not yet assigned - COG protocol | — | R 6 680 | 42d | — | — | — | — | — |
COG ACNS0332 Protocol B Variant not yet assigned - COG protocol | — | R 6 680 | 42d | — | — | — | — | — |
COG ACNS0331 Standard Dose CSRT with Reduced Volume Boost to Tumor Bed N/A - secondary systemic drug Partial | — | R 2 034 | 42d | — | — | — | — | — |
COG ACNS0331 Standard Dose CSRT with Standard Volume Boost N/A - secondary systemic drug Partial | — | R 2 034 | 42d | — | — | — | — | — |
4 of 4 regimens shown